Center-Authored Papers

Filters: Author is Mostaghel, Elahe A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2008
Mostaghel EA, Nelson PS.  2008.  Intracrine androgen metabolism in prostate cancer progression: mechanisms of castration resistance and therapeutic implications.. Best practice & research. Clinical endocrinology & metabolism. 22(2):243-58. Abstract
Marks LS, Mostaghel EA, Nelson PS.  2008.  Prostate tissue androgens: history and current clinical relevance.. Urology. 72(2):247-54. Abstract
Montgomery BR, Mostaghel EA, Vessella R, Hess DL, Kalhorn TF, Higano CS, True LD, Nelson PS.  2008.  Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth.. Cancer research. 68(11):4447-54. Abstract
2009
Harris WP, Mostaghel EA, Nelson PS, Montgomery B.  2009.  Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion.. Nature clinical practice. Urology. 6(2):76-85. Abstract
Mendiratta P, Mostaghel EA, Guinney J, Tewari AK, Porrello A, Barry WT, Nelson PS, Febbo PG.  2009.  Genomic strategy for targeting therapy in castration-resistant prostate cancer.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 27(12):2022-9. Abstract
Wang D, Montgomery BR, Schmidt LJ, Mostaghel EA, Huang H, Nelson PS, Tindall DJ.  2009.  Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression.. Cancer research. 69(24):9448-56. Abstract
Mostaghel EA, Montgomery B, Nelson PS.  2009.  Castration-resistant prostate cancer: targeting androgen metabolic pathways in recurrent disease.. Urologic oncology. 27(3):251-7. Abstract
2010
Sun S, Sprenger CCT, Vessella RL, Haugk K, Soriano K, Mostaghel EA, Page ST, Coleman IM, Nguyen HM, Sun H et al..  2010.  Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant.. The Journal of clinical investigation. 120(8):2715-30. Abstract
Mostaghel EA, Geng L, Holcomb I, Coleman IM, Lucas J, True LD, Nelson PS.  2010.  Variability in the androgen response of prostate epithelium to 5alpha-reductase inhibition: implications for prostate cancer chemoprevention.. Cancer research. 70(4):1286-95. Abstract
2011
Mostaghel EA, Plymate S.  2011.  New hormonal therapies for castration-resistant prostate cancer.. Endocrinology and metabolism clinics of North America. 40(3):625-42,x. Abstract
Mostaghel EA, Marck BT, Plymate SR, Vessella RL, Balk S, Matsumoto AM, Nelson PS, Montgomery BR.  2011.  Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(18):5913-25. Abstract
Cai C, Chen S, Ng P, Bubley GJ, Nelson PS, Mostaghel EA, Marck B, Matsumoto AM, Simon N, Wang H et al..  2011.  Intratumoral De Novo Steroid Synthesis Activates Androgen Receptor in Castration Resistant Prostate Cancer and is Upregulated by Treatment with CYP17A1 Inhibitors.. Cancer research. 71(20):6503-13. Abstract
Page ST, Lin DW, Mostaghel EA, Marck BT, Wright JL, Wu J, Amory JK, Nelson PS, Matsumoto AM.  2011.  Dihydrotestosterone administration does not increase intraprostatic androgen concentrations or alter prostate androgen action in healthy men: a randomized-controlled trial.. The Journal of clinical endocrinology and metabolism. 96(2):430-7. Abstract
Wright JL, Kwon EM, Ostrander EA, Montgomery BR, Lin DW, Vessella R, Stanford JL, Mostaghel EA.  2011.  Expression of SLCO transport genes in castration-resistant prostate cancer and impact of genetic variation in SLCO1B3 and SLCO2B1 on prostate cancer outcomes.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(4):619-27. Abstract
Meng J, Mostaghel EA, Vakar-Lopez F, Montgomery B, True L, Nelson PS.  2011.  Testosterone regulates tight junction proteins and influences prostatic autoimmune responses.. Hormones & cancer. 2(3):145-56. Abstract
Mostaghel EA, Wright JL, Montgomery B, Stanford JL.  2011.  SLCO Transport Genes in Prostate Cancer--Response.. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 20(10):2326-7.
2012
Mostaghel EA, Lin DW, Amory JK, Wright JL, Marck BT, Nelson PS, Matsumoto AM, Bremner WJ, Page ST.  2012.  Impact of Male Hormonal Contraception on Prostate Androgens and Androgen Action in Healthy Men: A Randomized, Controlled Trial.. The Journal of clinical endocrinology and metabolism. Abstract
Mostaghel EA, Solomon KR, Pelton K, Freeman MR, Montgomery BR.  2012.  Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors.. PloS one. 7(1):e30062. Abstract
2013
Tamae D, Byrns M, Marck B, Mostaghel EA, Nelson PS, Lange P, Lin D, Taplin M-E, Balk S, Ellis W et al..  2013.  Development, validation and application of a stable isotope dilution liquid chromatography electrospray ionization/selected reaction monitoring/mass spectrometry (SID-LC/ESI/SRM/MS) method for quantification of keto-androgens in human serum.. The Journal of steroid biochemistry and molecular biology. 138C:281-289. Abstract
Mostaghel EA, Nelson PS, Lange P, Lin DW, Taplin ME, Balk S, Ellis W, Kantoff P, Marck B, Tamae D et al..  2014.  Targeted androgen pathway suppression in localized prostate cancer: a pilot study.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 32(3):229-37. Abstract
2014
Montgomery B, Cheng HH, Drechsler J, Mostaghel EA.  2014.  Glucocorticoids and prostate cancer treatment: friend or foe? Asian journal of andrology. Abstract
Yu Z, Chen S, Sowalsky AG, Voznesensky O, Mostaghel EA, Nelson PS, Cai C, Balk SP.  2014.  Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer.. Clinical cancer research : an official journal of the American Association for Cancer Research. Abstract
Mostaghel EA, Plymate SR, Montgomery B.  2014.  Molecular pathways: targeting resistance in the androgen receptor for therapeutic benefit.. Clinical cancer research : an official journal of the American Association for Cancer Research. 20(4):791-8. Abstract
Mostaghel EA, Morgan A, Zhang X, Marck BT, Xia J, Hunter-Merrill R, Gulati R, Plymate S, Vessella RL, Corey E et al..  2014.  Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis.. PloS one. 9(10):e111545. Abstract
Mostaghel EA, Lin DW.  2014.  Practical guide to the use of abiraterone in castration resistant prostate cancer.. The Canadian journal of urology. 21(2 Supp 1):57-63. Abstract